4eqM

Oracle earnings: Positioning for possible upside with options

Key points:

  • Oracle reports earnings on March 10: Analysts expect Oracle's Q3 FY2025 earnings to show an 8% YoY revenue growth to $14.4 billion and a 6% increase in EPS to $1.49. Key factors to watch include the transition of customers to cloud and AI services, AI monetization, and updates on the Stargate AI initiative.
  • Guidance for Q4 FY25 will be key: Investors will be looking for guidance on AI services growth in Q4 as that is key to meet full year guidance of double-digit revenue growth.
  • Synthetic long strategy: For investors looking to gain exposure to Oracle's potential upside without buying the stock outright, a synthetic long position can be an effective strategy. This involves buying a $155 call and selling a $155 put with the same expiration, allowing for upside participation with a lower initial investment.

Oracle (ORCL) is set to report its fiscal Q3 2025 earnings on Monday, March 10, 2025 after market close. The stock has declined 7% year-to-date (YTD) but remains up approximately 35% over the past 12 months. Broader tech sector weakness, competitive concerns following China’s launch of DeepSeek and other AI models, and tariff threats have pressured valuations ahead of the report.

Market expectations for Q3 earnings

Analysts have set high expectations for Oracle’s Q3 results:

  • Revenue growth: +8% YoY to $14.4 billion
  • EPS growth: +5.7% YoY to $1.49 (vs. +9.7% in Q2)
  • Average implied 1-day move: 9%

Key factors to watch

Customer transition to cloud and AI services

Oracle continues to shift its enterprise customer base from legacy database software to cloud-based and AI-driven solutions. As a result, Oracle’s cloud growth is catching up as a viable alternative to the three hyperscalers – Amazon Web Services, Microsoft and Google. However, Oracle has only mentioned the new, larger customer deals briefly earlier. Investors may be looking for more substantial updates on customer adoption rates and contract wins, and any such details could drive positive momentum in the stock.

AI monetization and infrastructure growth

A primary focal point will be Oracle’s ability to meet expectations for Infrastructure-as-a-Service (IaaS) revenue growth, as this is key for Oracle to achieve its double-digit revenue growth guidance for full year. Analysts expect 56% IaaS revenue growth in Q4 on a constant currency basis. This segment is a key growth driver, and any commentary around AI infrastructure monetization strategies could significantly influence the stock’s post-earnings reaction.

Update on Stargate AI initiative

Oracle’s involvement in the up-to-$500 billion AI infrastructure project, Stargate, a JV with SoftBank and OpenAI, could be a major talking point. Any new details regarding its scale, execution timeline, and Oracle’s financial commitment may outweigh other earnings details in the eyes of investors.

Capital expenditures and free cash flow outlook

Oracle is expected to increase capital expenditures by nearly 30% this fiscal year to support its cloud and AI ambitions. This could be a key focus, especially after DeepSeek’s claims to bring AI models at a fraction of the cost that US tech players have been spending. While this investment is necessary for long-term growth, it may pressure short-term free cash flow. Investors will be looking for guidance on when spending may taper off and how free cash flow could rebound in later years.

Foreign exchange headwinds

Over 40% of Oracle’s revenue comes from international markets. A strong U.S. dollar could negatively impact reported earnings by reducing the dollar value of foreign sales. Investors will be closely watching whether currency fluctuations present a meaningful drag on results, but these are likely to be considered a tactical interference with US dollar on a bearish trend now easing concerns about its impact on earnings in Q4.


Using a synthetic long for bullish exposure

For investors looking to gain exposure to Oracle’s potential upside after earnings without buying the stock outright, a synthetic long position can be an effective strategy.

Synthetic long setup (Example strategy at $155 current price)

  • Buy the $155 call expiring in 1-2 months
  • Sell the $155 put with the same expiration
  • Objective: Replicate stock ownership with less capital upfront

Outcome Scenarios

  1. Stock rises above $155 (profitable trade): If Oracle rises above $155, the call option gains value while the short put expires worthless. This mimics the effect of holding the stock and allows for upside participation with a lower initial investment.
  2. Stock stays around $155 (minimal impact): If Oracle remains near $155 by expiration, the position remains largely unchanged, with minor gains or losses depending on time decay and implied volatility changes.
  3. Stock declines below $155 (potential obligation to buy): If Oracle drops, the call option loses value while the short put could result in the obligation to buy shares at $155. This is similar to stock ownership, meaning the trader should be willing to take on the stock if assigned.
10_CHCA_Oracle
Source: Saxo

Why use a synthetic long?

  • Lower capital requirement: Unlike buying shares, this strategy requires less capital while still gaining upside exposure.
  • Leverage benefits: Allows traders to benefit from potential stock gains without tying up large amounts of capital.
  • Flexibility: Can be adjusted or closed before expiration if Oracle's earnings reaction is different than expected.

Final thoughts

Oracle’s Q3 earnings will be closely watched for AI-related developments, cloud growth, and capex guidance. While risks such as foreign exchange pressures and valuation concerns persist, strong execution on key growth initiatives could drive a significant stock reaction. A synthetic long strategy provides a way to gain exposure to Oracle’s upside while using less capital than traditional stock ownership, making it an effective approach for bullish investors.

Disclaimer

Confidentiality and Usage:
You may not reproduce, distribute, or transmit this material or any portion thereof without prior written permission from Saxo.

Nature of Information:
The information provided herein is based on current market conditions and analysts' opinions, which may reflect personal views of the author, and are subject to change without notice. This material does not include a record of any trading prices, or an offer of, or solicitation for, or endorsement to enter into any transaction in any investment product. Any forecast on the economy, markets and economic trends of the markets provided is not necessarily indicative of the future or likely performance of the investment product subject of this material.

Responsibility and Liability:
Saxo accepts no liability for any use that may be made of these comments or for any consequences that arise from such use. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

The information provided in this material is solely for information only. It is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. Accordingly, it should not be relied on or treated as a substitute for specific advice concerning specific situations of any person. Please seek advice from a financial adviser regarding the suitability of any investment product taking into account your specific investment objectives, financial situation or particular needs before you make a commitment to purchase an investment product. In the event that you choose not to seek advice from a financial adviser, you should consider whether any investment product mentioned in this publication is suitable for you.

Notwithstanding the above, insofar as any information provided herein contains research analyses or reports concerning any investment product authored by any foreign research house and is issued or promulgated to a person in Singapore who is not an accredited investor, expert investor, and/or institutional investor, Saxo Capital Market Pte. Ltd. accepts legal responsibility for the contents of this material to the extent required by law. Recipients of such material are to contact Saxo Capital Markets Pte. Ltd. in respect of any matters arising from, or in connection with, this material.

Risk Disclosure:
Trading in investment products involve significant risk, including the risk of losing your entire investment. Historical returns are not a guarantee of future returns. Prices can both rise and fall, and there is a risk that you will not get back the money you invested.

Conflicts of interest:
The author may hold positions in the investment products mentioned. The author does not own positions in the underlying investment product exceeding 0.5% of its market capitalisation, save as otherwise declared. The author is not permitted to trade the mentioned investment products within the first 24 hours after the publication of this article.

Saxo maintains partnerships with companies that compensate Saxo for promotional activities conducted on its platform. Additionally, Saxo has agreements with certain partners who provide retrocession contingent upon clients purchasing specific investment products offered by these partners. While Saxo receives compensation from these partnerships, all content is conducted with the intention of providing clients with valuable options and information.

Publication details:
If any listed companies are the subject of the material, the content has not been submitted to the companies in question prior to publication.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Saxo is part of the J. Safra Sarasin Group.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.